샘플 요청 목록

 카트 문의
시장보고서
상품코드
1424106

수혈 진단 시장 점유율, 규모, 동향, 산업 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2024-2032년)

Blood Transfusion Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Product (Instruments, Reagents & Kits, Others); By Application; By End-Use; By Region; Segment Forecast, 2024 - 2032
발행일: | 리서치사: Polaris Market Research | 페이지 정보: 영문 117 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 수혈 진단 시장 규모는 2032년까지 66억 6,000만 달러에 달할 것으로 예상됩니다. 이 보고서는 현재 시장 역학에 대한 자세한 인사이트와 향후 시장 성장에 대한 분석을 제공합니다.

혈액은행에서 자동화로의 전환이 증가함에 따라 혈액은행들은 검사 완료에 필요한 시간을 단축하고 필수 검사를 수행하는 데 필요한 인력 부족을 해소할 수 있을 것으로 예상됩니다. 자동화 시스템 도입은 이러한 시설들이 워크플로우를 간소화하고 전반적인 효율성을 개선하는 데 도움이 될 것으로 예상됩니다.

혈액 및 혈액 제제의 적절한 취급 및 보관은 품질 관리 방법의 실행과 마찬가지로 수혈 진단에 있어 매우 중요합니다. 혈액은 정기적으로 미생물 오염 검사를 실시하고 수혈용으로 승인되기 전에 정확한 라벨링과 문서화가 이루어지도록 철저히 검사합니다.

암, 겸상 적혈구 빈혈, 지중해 빈혈과 같은 만성 질환이 전 세계적으로 증가함에 따라 수혈이 증가하고 있으며, 이는 시장 성장에 기여하고 있습니다. 또한 교통사고, 외상, 수혈 시술이 증가함에 따라 수혈 진단에 대한 수요도 증가하고 있습니다.

수혈 진단의 사용을 의무화하는 정부의 노력과 입법 조치는 시장 성장에 필수적입니다. 특히 미국 식품의약국(FDA)이 제정한 규정은 헌혈 혈액의 바이러스 감염을 감지하기 위해 핵산 검사(NAT)를 사용하도록 의무화하고 있습니다. 이 중요한 단계는 혈액 매개 질환의 감염 위험을 크게 줄일 수 있습니다.

핵산 검사, 면역 분석 등 진단 검사법의 자동화와 기술 발전으로 혈액 검사의 정확성과 효율성이 향상되고 있습니다. 마찬가지로, 수혈 감염의 위험을 줄여 수혈의 안전성을 향상시키는 것이 중요하게 여겨지고 있습니다. 시장은 병원체를 신속하고 민감하게 검출하는 분자 진단 기술로 전환하고 있습니다. 혈액 안전에 대한 관심이 높아짐에 따라 수혈 진단 시장은 혈액 검사 및 수혈 절차의 전반적인 효율성을 개선하고 프로세스를 간소화하는 기술 혁신으로 계속 진화할 것으로 보입니다.

수혈 진단 시장 보고서 하이라이트

수혈 진단 시장에서 시약 및 키트 분야가 가장 큰 매출 점유율을 차지하고 있습니다. 의료 시설에서는 안전하고 효과적인 수혈을 위해 시약과 키트를 반복적으로 사용합니다. 이러한 필수 도구는 혈액형 분류 및 혈액형 분류를 포함한 다양한 목적으로 사용됩니다.

예측 기간 동안 질병 검진 부문이 가장 높은 시장 점유율을 차지합니다. 질병 검진은 환자의 건강을 보호하고 제공된 혈액으로 인한 감염 확산을 방지하기 위해 필수적입니다. 수혈의 안전성은 감염 전파를 예방하는 데 있어 점점 더 중요해지고 있습니다.

북미는 높은 가처분 소득, 유리한 상환 정책, 높은 건강 인식, 잘 정비된 의료 인프라로 인해 수혈 진단 시장에서 가장 큰 시장 점유율을 차지하고 있습니다.

아시아태평양이 수혈 진단 시장에서 가장 빠르게 성장한 이유는 소득이 낮은 국가에서 TTI의 빈도가 높고 질병 검사 기술에 대한 수요가 높기 때문입니다. 그러나 헌혈 센터와 헌혈자 수는 꾸준히 증가하고 있습니다. 또한 수혈 전 검사에 대한 수요도 증가하고 있습니다.

목차

제1장 서론

제2장 주요 요약

제3장 조사 방법

제4장 세계의 수혈 진단 시장에 관한 인사이트

  • 수혈 진단 - 업계 현황
  • 수혈 진단 시장 역학
    • 성장 촉진요인과 기회
    • 성장 억제요인과 과제
  • PESTLE 분석
  • 수혈 진단 시장 업계 동향

제5장 세계의 수혈 진단 시장 : 제품별

  • 주요 조사 결과
  • 서론
  • 기기
  • 시약·키트
  • 기타

제6장 세계의 수혈 진단 시장 : 용도별

  • 주요 조사 결과
  • 서론
  • 혈액형 검사
  • 질병 스크리닝

제7장 세계의 수혈 진단 시장 : 최종 용도별

  • 주요 조사 결과
  • 서론
  • 병원
  • 혈액은행
  • 진단 연구소
  • 기타

제8장 세계의 수혈 진단 시장 : 지역별

  • 주요 조사 결과
  • 서론
    • 수혈 진단 시장 평가 : 지역별, 2019-2032년
  • 북미
    • 제품별, 2019-2032년
    • 용도별, 2019-2032년
    • 최종 용도별, 2019-2032년
    • 미국
    • 캐나다
  • 유럽
    • 제품별, 2019-2032년
    • 용도별, 2019-2032년
    • 최종 용도별, 2019-2032년
    • 영국
    • 프랑스
    • 독일
    • 이탈리아
    • 스페인
    • 네덜란드
    • 오스트리아
  • 아시아태평양
    • 제품별, 2019-2032년
    • 용도별, 2019-2032년
    • 최종 용도별, 2019-2032년
    • 중국
    • 인도
    • 말레이시아
    • 일본
    • 인도네시아
    • 한국
  • 중동 및 아프리카
    • 제품별, 2019-2032년
    • 용도별, 2019-2032년
    • 최종 용도별, 2019-2032년
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 남아프리카공화국
  • 라틴아메리카
    • 제품별, 2019-2032년
    • 용도별, 2019-2032년
    • 최종 용도별, 2019-2032년
    • 멕시코
    • 브라질
    • 아르헨티나

제9장 경쟁 상황

  • 확장과 인수 분석
    • 확대
    • 인수
  • 제휴/협업/합의/공개

제10장 기업 개요

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Diamond Diagnostics
  • Diagnostica Stago
  • Electro Medical Technologies
  • F. Hoffmann-La Roche Ltd
  • Grifols S.A.
  • Immucor Inc.
  • Ortho Clinical Diagnostics
  • Quotient Ltd
ksm 24.02.23

The global blood transfusion diagnostics market size is expected to reach USD 6.66 billion by 2032, according to a new study by Polaris Market Research. The report "Blood Transfusion Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Product (Instruments, Reagents & Kits, Others); By Application; By End-Use; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising shift toward automation in blood banks is anticipated to aid blood collection facilities by reducing the time required to complete tests and addressing the workforce shortage needed to conduct essential tests. The implementation of automated systems is expected to help these facilities streamline their workflow and improve overall efficiency.

The proper handling and storage of blood and blood products is critical to blood transfusion diagnostics, as is the implementation of quality control methods. Blood is tested for microbial contamination on a regular basis, and it is thoroughly examined to ensure accurate labeling and documentation before it is approved for transfusion.

The global rise in chronic diseases such as cancer, sickle cell anemia, and thalassemia has resulted in an increase in blood transfusions, which has contributed to the market's growth. The demand for blood transfusion diagnostics has also increased as the number of traffic accidents, trauma cases, and blood transfusion procedures has increased.

Government initiatives and legislative measures mandating the use of blood transfusion diagnostics are critical to market growth. Particularly, regulations enacted by the United States Food and Drug Administration (FDA) require the use of Nucleic Acid Testing (NAT) to detect viral infections in donated blood. This critical step significantly reduces the risk of blood-borne disease transmission.

Automation and technological advancements in diagnostic testing methods, such as nucleic acid testing and immunoassays, have enhanced the accuracy and efficiency of blood screening. Similarly, there is a growing emphasis on improving the safety of blood transfusions by reducing the risk of transfusion-transmissible infections. The market has shifted toward molecular diagnostic techniques for the rapid and sensitive detection of pathogens. With an emphasis on blood safety, the blood transfusion diagnostics market is likely to continue evolving with innovations that simplify processes and improve the overall efficiency of blood testing and transfusion procedures.

Blood Transfusion Diagnostics Market Report Highlights

The reagent & kits segment held the largest revenue share in the blood transfusion diagnostics market. Medical facilities rely on the repeated use of reagents and kits to ensure the safe and effective transfusion of blood. These essential tools are used for a variety of purposes, including blood grouping and typing.

The disease screening segment accounted for the highest market share during the forecast period. Disease screening is essential in protecting the recipient's health and preventing the spread of infections through donated blood. Blood transfusion safety has become increasingly important in the prevention of infection transmission.

North America accounted for the largest market share in the blood transfusion diagnosis market, owing to the high disposable income, favorable reimbursement policies, rising health awareness, and a well-established healthcare infrastructure.

The Asia-Pacific region witnessed for the fastest growth in the blood transfusion diagnostics market owing to the high frequency of TTIs in countries with low income which give rise to a huge need for illness screening techniques. However, the number of blood donation centers and donors is steadily increasing. Additionally, there is an increase in demand for pre-transfusion testing.

The global key market players include Abbott Laboratories, Bio-Rad Laboratories, Inc., Diamond Diagnostics, Diagnostica Stago, Electro Medical Technologies, F. Hoffman-La Roche Ltd., Grifols S.A., Immucor Inc., Ortho Clinical Diagnosis, Quotient Ltd.

Polaris Market Research has segmented the Blood Transfusion Diagnostics market report based on product, application, end-use, and region:

Blood Transfusion Diagnostics, Product Outlook (Revenue - USD Billion, 2019 - 2032)

  • Instrument
  • Reagents & Kits
  • Others

Blood Transfusion Diagnostics, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Blood Grouping
  • Disease Screening
  • Serological
  • Molecular

Blood Transfusion Diagnostics, End-Use Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospitals
  • Blood Banks
  • Diagnostic Laboratories
  • Others

Blood Transfusion Diagnostics, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Blood Transfusion Diagnostics Market Insights

  • 4.1. Blood Transfusion Diagnostics - Industry snapshot
  • 4.2. Blood Transfusion Diagnostics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Improvements in the diagnostic technologies will drive the growth of the market
      • 4.2.1.2. Increase in the number of trauma & road accident cases will bolster the growth of the market
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Shortage of blood donations as compared to the demand will hamper on the growth of the market
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Blood Transfusion Diagnostics Market Industry trends

5. Global Blood Transfusion Diagnostics Market Assessment by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
  • 5.3. Instruments
    • 5.3.1. Global Blood Transfusion Diagnostics Market, by Instruments, by Region, 2019 - 2032 (USD Billion)
  • 5.4. Reagents & Kits
    • 5.4.1. Global Blood Transfusion Diagnostics Market, by Reagents & Kits, by Region, 2019 - 2032 (USD Billion)
  • 5.5. Others
    • 5.5.1. Global Blood Transfusion Diagnostics Market, by Others, by Region, 2019 - 2032 (USD Billion)

6. Global Blood Transfusion Diagnostics Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
  • 6.3. Blood Grouping
    • 6.3.1. Global Blood Transfusion Diagnostics Market, by Blood Grouping, By Region, 2019 - 2032 (USD Billion)
  • 6.4. Disease Screening
    • 6.4.1. Global Blood Transfusion Diagnostics Market, by Disease Screening, by Region, 2019 - 2032 (USD Billion)
    • 6.4.2. Serological
      • 6.4.2.1. Serological Screening Market, by Disease, by Region, 2019 - 2032 (USD Billion)
    • 6.4.3. Molecular
      • 6.4.3.1. Molecular Screening Screening Market, by Disease, by Region, 2019 - 2032 (USD Billion)

7. Blood Transfusion Diagnostics Market Assessment by End-Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Blood Transfusion Diagnostics Market, By End-Use, 2019 - 2032 (USD Billion)
  • 7.3. Hospitals
    • 7.3.1. Global Blood Transfusion Diagnostics Market, by Hospitals, by Region, 2019 - 2032 (USD Billion)
  • 7.4. Blood Banks
    • 7.4.1. Global Blood Transfusion Diagnostics Market, by Blood Banks, by Region, 2019 - 2032 (USD Billion)
  • 7.5. Diagnostic Laboratories
    • 7.5.1. Global Blood Transfusion Diagnostics Market, by Diagnostic Laboratories, by Region, 2019 - 2032 (USD Billion)
  • 7.6. Others
    • 7.6.1. Global Blood Transfusion Diagnostics Market, by Others, by Region, 2019 - 2032 (USD Billion)

8. Blood Transfusion Diagnostics Market Assessment by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Blood Transfusion Diagnostics Market Assessment, By Geography, 2019 - 2032 (USD Billion)
  • 8.3. Blood Transfusion Diagnostics Market - North America
    • 8.3.1. North America: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
    • 8.3.2. North America: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
    • 8.3.3. North America: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
    • 8.3.4. Blood Transfusion Diagnostics Market - U.S.
      • 8.3.4.1. U.S.: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
      • 8.3.4.2. U.S.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
      • 8.3.4.3. U.S.: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
    • 8.3.5. Blood Transfusion Diagnostics Market - Canada
      • 8.3.5.1. Canada: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
      • 8.3.5.2. Canada.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
      • 8.3.5.3. Canada: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
  • 8.4. Blood Transfusion Diagnostics Market - Europe
    • 8.4.1. Europe: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
    • 8.4.2. Europe.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
    • 8.4.3. Europe: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
    • 8.4.4. Blood Transfusion Diagnostics Market - UK
      • 8.4.4.1. UK: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
      • 8.4.4.2. UK.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
      • 8.4.4.3. UK: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
    • 8.4.5. Blood Transfusion Diagnostics Market - France
      • 8.4.5.1. France: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
      • 8.4.5.2. France.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
      • 8.4.5.3. France: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
    • 8.4.6. Blood Transfusion Diagnostics Market - Germany
      • 8.4.6.1. Germany: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
      • 8.4.6.2. Germany.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
      • 8.4.6.3. Germany: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
    • 8.4.7. Blood Transfusion Diagnostics Market - Italy
      • 8.4.7.1. Italy: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
      • 8.4.7.2. Italy.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
      • 8.4.7.3. Italy: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
    • 8.4.8. Blood Transfusion Diagnostics Market - Spain
      • 8.4.8.1. Spain: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
      • 8.4.8.2. Spain.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
      • 8.4.8.3. Spain: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
    • 8.4.9. Blood Transfusion Diagnostics Market - Netherlands
      • 8.4.9.1. Netherlands: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
      • 8.4.9.3. Netherlands: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
    • 8.4.10. Blood Transfusion Diagnostics Market - Austria
      • 8.4.10.1. Austria: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
      • 8.4.10.2. Austria.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
      • 8.4.10.3. Austria: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
  • 8.5. Blood Transfusion Diagnostics Market - Asia-Pacific
    • 8.5.1. Asia Pacific: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
    • 8.5.3. Asia Pacific: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
    • 8.5.4. Blood Transfusion Diagnostics Market - China
      • 8.5.4.1. China: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
      • 8.5.4.2. China.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
      • 8.5.4.3. China: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
    • 8.5.5. Blood Transfusion Diagnostics Market - India
      • 8.5.5.1. India: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
      • 8.5.5.2. India.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
      • 8.5.5.3. India: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
    • 8.5.6. Blood Transfusion Diagnostics Market - Malaysia
      • 8.5.6.1. Malaysia: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
      • 8.5.6.3. Malaysia: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
    • 8.5.7. Blood Transfusion Diagnostics Market - Japan
      • 8.5.7.1. Japan: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
      • 8.5.7.2. Japan.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
      • 8.5.7.3. Japan: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
    • 8.5.8. Blood Transfusion Diagnostics Market - Indonesia
      • 8.5.8.1. Indonesia: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
      • 8.5.8.3. Indonesia: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
    • 8.5.9. Blood Transfusion Diagnostics Market - South Korea
      • 8.5.9.1. South Korea: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
      • 8.5.9.2. South Korea.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
      • 8.5.9.3. South Korea: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
  • 8.6. Blood Transfusion Diagnostics Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
    • 8.6.4. Blood Transfusion Diagnostics Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
    • 8.6.5. Blood Transfusion Diagnostics Market - UAE
      • 8.6.5.1. UAE: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
      • 8.6.5.2. UAE.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
      • 8.6.5.3. UAE: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
    • 8.6.6. Blood Transfusion Diagnostics Market - Israel
      • 8.6.6.1. Israel: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
      • 8.6.6.2. Israel.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
      • 8.6.6.3. Israel: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
    • 8.6.7. Blood Transfusion Diagnostics Market - South Africa
      • 8.6.7.1. South Africa: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
      • 8.6.7.2. South Africa.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
      • 8.6.7.3. South Africa: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
  • 8.7. Blood Transfusion Diagnostics Market - Latin America
    • 8.7.1. Latin America: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
    • 8.7.2. Latin America.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
    • 8.7.3. Latin America: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
    • 8.7.4. Blood Transfusion Diagnostics Market - Mexico
      • 8.7.4.1. Mexico: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
      • 8.7.4.2. Mexico.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
      • 8.7.4.3. Mexico: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
    • 8.7.5. Blood Transfusion Diagnostics Market - Brazil
      • 8.7.5.1. Brazil: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
      • 8.7.5.2. Brazil.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
      • 8.7.5.3. Brazil: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)
    • 8.7.6. Blood Transfusion Diagnostics Market - Argentina
      • 8.7.6.1. Argentina: Blood Transfusion Diagnostics Market, By Product, 2019 - 2032 (USD Billion)
      • 8.7.6.2. Argentina.: Blood Transfusion Diagnostics Market, By Application, 2019 - 2032 (USD Billion)
      • 8.7.6.3. Argentina: Blood Transfusion Diagnostics Market, By End Use, 2019 - 2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott Laboratories
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Bio-Rad Laboratories, Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Diamond Diagnostics
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Diagnostica Stago
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Electro Medical Technologies
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. F. Hoffmann-La Roche Ltd
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Grifols S.A.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Immucor Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Ortho Clinical Diagnostics
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Quotient Ltd
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제